Tuesday, August 18, 2009

Glaxo Starts Testing Swine Flu Vaccine With Additive

The vaccine contains an experimental additive called an adjuvant, which is designed to boost a patient’s immune response and extend limited supplies of the vaccine.
The U.S. Health and Human Services Department declared a public health emergency over swine flu in April, and the Food and Drug Administration has the power to allow the use of unapproved medical products during such a crisis.
READ MORE HERE
http://www.bloomberg.com/apps/news?pid=20601102&sid=a5dGXc.OML_k